Before Dengue Is Implicated as the Cause of Polyradiculitis, the Infection Must Be Confirmed by Nucleic Acid Amplification Testing or Cell Cultures Authors: Josef Finsterer Published: 2026 We read with interest the article by Kumar et al. regarding a case series of five patients with Guillain–Barré syndrome (GBS), specifically, the subtypes acute inflammatory demyelinating polyneuropathy (n = 4) and acute motor and sensory axonal neuropathy (n = 1), in whom dengue virus was identified as the trigger. 1 All five patients experienced fever 11–15 days prior to the onset of neurological deficits. 1 Following treatment with intravenous immunoglobulin, all patients showed partial recovery at the 1-month follow-up (modified Hughes scale: grades 1–4). 1 While the study is promising, several points warrant discussion. First, diagnosing dengue fever based solely on immunoglobulin M (IgM) presents several significant drawbacks: early infections may be missed, distinguishing between current and past infection is impossible (due to long-term persistence), and cross-reactivity with other flaviviruses can lead to false-positive results. 2 Therefore, it would have been important to test the five patients for other flaviviruses as well (e.g., Zika, yellow fever, West Nile, Japanese encephalitis, tick-borne encephalitis, Omsk haemorrhagic fever and hepatitis C viruses). Since IgM antibodies can remain detectable for up to 6 months after a dengue infection, 3 it is conceivable that the GBS in at least four of the five patients was caused by something other than dengue. Furthermore, the sensitivity of the NS1 test is only 55%–70%, 4 suggesting that the dengue diagnosis for Patient 2 could also have been a false positive. 1 The gold standard for diagnosing dengue fever is the nucleic acid amplification test (NAAT), which confirms an acute dengue infection. The virus can also be reliably detected through histological examination of affected tissues. Cell cultures allow for the recovery of infectious viruses for further research and are suitable for a wide range of sample materials. Another point is that alternative triggers for GBS were not sufficiently ruled out. Before the dengue virus can be considered the cause of GBS, alternative triggers must be carefully excluded. These include Campylobacter jejuni (the most common cause of GBS), Haemophilus influenzae, Mycoplasma pneumoniae, Escherichia coli, varicella-zoster virus, human immunodeficiency virus, Zika virus, Epstein–Barr virus, influenza virus, SARS-CoV-2, hepatitis viruses A, B, C, D and E, cytomegalovirus, rubella, West Nile virus, Japanese encephalitis virus and chikungunya. 5 In addition, immunological disorders, trauma and sepsis must be considered as potential triggers for GBS. 5 A third point is that there was no report on whether the five patients exhibited other symptoms of dengue infection in addition to fever and GBS. During the febrile phase (days 1–7), patients often present with the dengue triad (headache, retro-orbital pain, severe muscle, joint or bone pain) as well as facial flushing, pharyngeal erythema, nosebleeds or bleeding gums. During the critical phase, abdominal pain, persistent vomiting, oedema, mucosal bleeding, lethargy, extreme exhaustion and sudden restlessness may occur. Blood tests during this phase reveal haemoconcentration and thrombocytopenia. 6 Did the five patients exhibit any of these symptoms? In summary, dengue should not be attributed as the trigger for GBS unless all alternative triggers have been carefully ruled out and the dengue infection has been confirmed via NAAT or cell culture. The author declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article. Funding: The author received no financial support for the research, authorship and/or publication of this article. ORCID iD: Josef Finsterer https://orcid.org/0000-0003-2839-7305 Author Contribution JF: Design, literature search, discussion, first draft, critical comments, final approval. Availability of Data and Material All data are available from the corresponding author. Patient Consent Not applicable. Statement of Ethics This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors. References Associated Data Data Availability Statement All data are available from the corresponding author.